Connect with us

Technology

Ivím Health Launches Revolutionary Corporate Weight Loss Program

Published

on

Elevating Workplace Wellness Through Clinically Crafted Solutions

COLUMBUS, Ohio, July 8, 2024 /PRNewswire/ — Ivím Health, a leading provider of GLP-1 weight loss programs, is launching Ivím at Work. This first-of-its-kind corporate wellness program, focused on optimizing weight management and elevating employee health and productivity, is created in partnership with Xevant, a leading provider of custom data analytics and insurance claims processing solutions. A breakthrough in workplace wellness, this program stands out by offering personalized GLP-1 weight management therapies, supported by a comprehensive, dedicated care team and tailored to the modern workforce.

Ivím Health aims to transform workplace wellness. “We’re creating a new gold standard for employee health benefit programs,” said Ivím’s Chief Medical Officer, Dr. Taylor Kantor. “Ivím at Work meets the growing need of a GLP-1 benefits program that can both manage supply chain constraints while lowering GLP-1 medication pricing. But medical weight loss is more than just medication. The program combines the benefits of GLP-1 medications with expert medical insights to deliver unique, data-driven and outcome-based personalized care, ensuring every patient receives the support they need in the form in which they need it.”

Developed by a team of medical experts, Ivím’s corporate program leverages the latest breakthroughs in obesity care and medical technology for health improvement. Dr. Jessica Cortazzo, Ivím’s Medical Director and a diplomate of the American Board of Obesity Medicine (ABOM), went on to highlight, “Our approach to medical weight loss utilizes customized GLP-1 care plans that significantly improve employee biomarkers, enhance employee well-being, engagement, and company performance, while also providing significant cost savings through claims reductions and rebate programs to both employers and employees. It’s a win-win for everyone.”

Through the recently announced partnership with Xevant, Ivím at Work now provides real-time data to employers on program utilization, group health outcomes, and cost savings analysis. By targeting health risks and providing measurable health improvements, the corporate program offers companies a strong negotiation position for lowering premiums. In addition, through the shortages currently being faced in GLP-1 supply chains, Ivím’s corporate programs offer differentiated supply chain access to provide greater GLP-1 medication access to employees.

Ivím tailors each corporate program to align with the company’s health goals, engaging employees through interactive sessions and digital platforms. Continuous support and optimization ensure the program’s success in promoting improved health and productivity.

“A healthy workforce is the backbone of a successful business,” Dr. Kantor asserts. “Investing in employee wellness not only boosts health and productivity but also yields impressive savings on insurance costs.”

For more details on how Ivím’s corporate program can benefit your company, visit www.ivimhealth.com/ivim-at-work/ or email IvimCorporateProgram@ivimhealth.com.

About Ivím Health: Ivím Health takes a holistic approach to obesity care, centering on patient care teams, community connection, and comprehensive support. This belief—that visibility and support are pivotal to success—fuels their mission. Ivím’s wellness plans, crafted by experts and available entirely online, pave a custom-tailored path to health transformation. Supported by an integrated care team of physicians, nurses, nutritionists, health coaches, and others, Ivím Health accompanies each patient through every phase of their wellness journey. Furthermore, the resourceful Ivím community offers a space for sharing, learning, and inspiring, complemented by a mobile health app that ensures seamless connection with your care team and real-time tracking of your progress. In this nurturing ecosystem, Ivím not only promises a journey towards better health but guarantees a partnership where every step towards wellness is a shared achievement.

About Xevant: Xevant’s revolutionary data analytics platform infuses real-time automation across the entire pharmacy benefits ecosystem driving the lowest net costs and improving overall health. With a focus on customer success and a commitment to innovation, Xevant is the partner businesses of all sizes trust to transform their pharmacy benefit and reporting practices for more proactive, efficient benefit management that delivers results in a fast-changing pharmacy landscape.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ivim-health-launches-revolutionary-corporate-weight-loss-program-302190204.html

SOURCE Ivim Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Infineon wins patent infringement case against Innoscience

Published

on

By

MUNICH, June 18, 2026 /PRNewswire/ — The District Court Munich, Germany (Landgericht München I) today ruled in favor of Infineon Technologies in two further of the patent infringement cases – specifically one based on a patent one based on a utility model – concerning gallium nitride (GaN) technology between Infineon and Innoscience.

The cases concern the unauthorized use of GaN technologies patented by Infineon by the Chinese company Innoscience. With today’s rulings, the court prohibits Innoscience from manufacturing, selling, and marketing additional patent-infringing products in Germany. Furthermore, the court has ordered Innoscience to pay damages to Infineon.

This marks Innoscience’s third and fourth legal defeat in a series of court cases, each of which found that Innoscience’s products infringe Infineon’s patents. Courts and authorities in both Germany and the United States have repeatedly concluded that Innoscience’s products infringe Infineon’s intellectual property rights. Prior rulings include the decision against Innoscience from August 1, 2025, in an initial German proceeding. Furthermore, on May 7, the Full Commission of the U.S. International Trade Commission (ITC) found that Innoscience had infringed an Infineon patent in the field of gallium nitride (GaN) technology. Additional proceedings regarding the infringement of other Infineon patents are pending in the U.S. and Germany.

GaN plays a pivotal role in enabling high-performance and energy-efficient power systems in a broad range of applications, including renewable energy systems, data centers, industrial automation, and electric vehicles (EVs).

“Today’s ruling demonstrates the value of our GaN portfolio and underscores our commitment to vigorously defending our intellectual property and promoting fair competition,” said Johannes Schoiswohl, Senior Vice President and Head of Infineon’s GaN Systems Business Line.

Infineon continuously strengthens its position as a leading integrated device manufacturer (IDM) in the GaN market with the industry’s broadest IP portfolio, comprising approximately 450 GaN patent families. The company remains dedicated to fostering innovation and advancing semiconductor technology to address the world’s most pressing challenges, from decarbonization to digital transformation.

About Infineon
Infineon Technologies AG is a global semiconductor leader in power systems and IoT. Infineon drives decarbonization and digitalization with its products and solutions. The Company had around 57,000 employees worldwide (end of September 2025) and generated revenue of about €14.7 billion in the 2025 fiscal year (ending 30 September). Infineon is listed on the Frankfurt Stock Exchange (ticker symbol: IFX) and in the USA on the OTCQX International over-the-counter market (ticker symbol: IFNNY).

Further information is available at www.infineon.com
This press release is available online at www.infineon.com/press
Follow us: Facebook – LinkedIn

Contact:
Andre Tauber,
andre.tauber@infineon.com,
Tel. +49 89 343 6705

View original content:https://www.prnewswire.co.uk/news-releases/infineon-wins-patent-infringement-case-against-innoscience-302804725.html

Continue Reading

Technology

The Inner Circle acknowledges Alan R. Mann as a Pinnacle Professional Member Inner Circle of Excellence

Published

on

By

MOORESVILLE, N.C., June 18, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Alan R. Mann is recognized as a Pinnacle Professional Member Inner Circle of Excellence for his contributions to Data Analytics and Decision Support.

Alan R. Mann has built a distinguished career in data analytics defined by precision, innovation, and a steadfast commitment to data integrity. With 36 years of experience spanning government, private sector, and health care environments, he is widely respected for transforming complex data into actionable insight that supports informed decision making and improved outcomes.

Since 2023, Mr. Mann has served as a data analyst and senior decision support analyst at Highmark Health, where he manages reporting package responsibilities for the Encompass team. In this role, he develops advanced programming that enables sales teams to deliver data driven client presentations, compare client profiles across multiple health care benefit metrics, and measure outcomes for up to nine chronic conditions.

Mr. Mann’s responsibilities also include evaluating additional coverage measurements and product performance metrics, conducting data discovery to integrate internal database sources, and reducing manual transcription through streamlined data workflows. He finalizes data integration efforts that improve reporting efficiency and supports enhancements to pharmacy focused reporting products, ensuring accuracy and consistency across all deliverables.

A critical component of his work involves designing comprehensive test plans to validate the accuracy and reliability of program outputs. When discrepancies or uncertainties arise, Mr. Mann rigorously retests and validates results, reinforcing his commitment to quality, precision, and trustworthy analytics. His expertise across government, health care, data science, and business analytics continues to add measurable value to the organizations he supports.

Mr. Mann earned a Bachelor of Arts degree from the University of Delaware and a Master of Science degree from Capella University. He further expanded his technical skill set through certification in artificial intelligence from the Texas McCombs School of Business. His professional affiliations include SAS, SASUG, Scouting America, and AEPhi, reflecting both his technical engagement and community involvement.

Outside of his professional work, Mr. Mann enjoys traveling, collecting model and toy trains, and playing guitar. He credits much of his success to the guidance of his mentor, Barry Morstan, and expresses deep gratitude to his wife, Louis, and his parents, Gilbert and Muriel, for their continued love and support.

Looking ahead, Mr. Mann plans to continue contributing to his organization while gradually preparing for the next phase of his professional journey, confident in the lasting impact of his work in data analytics and decision support.

Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com

View original content:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-alan-r-mann-as-a-pinnacle-professional-member-inner-circle-of-excellence-302804593.html

SOURCE The Inner Circle

Continue Reading

Technology

Aquarius.io Launches Press AI & PR Spotlight: Your New AI Team

Published

on

By

They Call it “The Unfair Advantage”.

LOS ANGELES, Jun 18, 2026 /PRNewswire/ — 

Talent is not enough without a team.

Most people do not lose because they lack talent. They lose because they do not have a team behind them. Aquarius is out to change that. Two new tools, Press AI and PR Spotlight, put a full news team and a full marketing department in one person’s hands. It is the kind of firepower everyone needs go scale. See it all at Aquarius.io.

Press AI: a full news team for one person

Press AI is a full news team for one person. Give it a story and it researches live sources, checks the facts, turns your interviews into clean, quotable transcripts, and hands back a finished piece with sources attached, ready to file. It does the work of an entire team, so one reporter can chase more leads, break more stories, and beat every deadline.

“Talent is everywhere. The team behind it is not,” said Chaela Harrell, a co-founder of Aquarius. “Aquarius gives one person the power of a whole company. We are your unfair advantage.”

PR Spotlight: your own marketing department

PR Spotlight is a full marketing department in a single tool. Answer a few questions and it researches your brand, then builds investor grade pitch decks and complete media kits, designs your logo, and even handles your contracts, letting you upload, send, sign, and receive them through DocuSign. Together, Press AI and PR Spotlight do the work of an entire team, putting serious media and marketing power in anyone’s hands. Press AI and PR Spotlight are available now at Aquarius.io. Take a look, test it and see what the hype is about. 

The rest of the Aquarius family

Press AI and PR Spotlight join a whole family of Aquarius tools: Muse Lab for image and video, Chronicles for cinematic storytelling, Viral AI for social content, and Aria, a voice driven executive assistant. The platform is self serve, so you only pay for what you make. Every tool is built on one idea: give one person the team they never had. That is your unfair advantage.

Press AI and PR Spotlight are the next step in what Aquarius set out to do: put professional grade tools in the hands of the people who were never handed a team.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aquariusio-launches-press-ai–pr-spotlight-your-new-ai-team-302804726.html

SOURCE Aquarius.io

Continue Reading

Trending